Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

ASTELLAS PHARMA INC (4503)

10
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Astellas Pharma : Transfer of Distribution Rights for Targocid® and Maalox®

09/08/2011 | 10:10pm US/Eastern

Astellas Pharma Inc. (“Astellas Pharma”; Headquarters: Chuo-ku, Tokyo; President and CEO: Yoshihiko Hatanaka) and sanofi-aventis K.K. (“sanofi-aventis”; Headquarters: Shinjuku-ku, Tokyo; Representative Director and President: Jez Moulding) announced that Astellas Pharma will transfer the rights to distribute the injectable antibiotics Targocid® (generic name: teicoplanin) and the treatment for peptic ulcer and gastritis Maalox® (generic name: dried aluminum hydroxide gel and magnesium hydroxide) to sanofi-aventis effective on January 1, 2012. This transfer of distribution rights is taking place based on the expiration of the contract.

<Products for which distribution rights will be transferred>

React to this article
Latest news on ASTELLAS PHARMA INC
03/27 MEDIVATION : and Astellas Release New Enzalutamide Data
03/27 ASTELLAS PHARMA INC : ex-dividend day for final dividend
03/24 ASTELLAS PHARMA : AND MEDIVATION ANNOUNCE NEW ENZALUTAMIDE DATA PRESENTED DURING..
03/23 ASTELLAS PHARMA : - announcement of marketing approval submission to mhlw (japan..
03/20 ASTELLAS PHARMA : Announcement of marketing approval submission to mhlw (japan) ..
03/18 ASTELLAS PHARMA : New Drug Administration Routes Findings Has Been Reported by R..
03/17 ASTELLAS PHARMA : - Notice of Completion of Acquisition of Own Shares (Under the..
03/17 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Kiklin® Capsules..
03/15 ASTELLAS PHARMA : Receives FDA Approval for CRESEMBA® (isavuconazonium sulfate) ..
03/15 ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 62 KB)
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF